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BACKGROUND: Fractional flow reserve (FFR) is commonly used to assess 
the functional significance of coronary artery disease but is theoretically 
limited in evaluating individual stenoses in serially diseased vessels. We 
sought to characterize the accuracy of assessing individual stenoses in 
serial disease using invasive FFR pullback and the noninvasive equivalent, 
fractional flow reserve by computed tomography (FFRCT). We subsequently 
describe and test the accuracy of a novel noninvasive FFRCT-derived 
percutaneous coronary intervention (PCI) planning tool (FFRCT-P) in 
predicting the true significance of individual stenoses.
METHODS AND RESULTS: Patients with angiographic serial coronary 
artery disease scheduled for PCI were enrolled and underwent prospective 
coronary CT angiography with conventional FFRCT-derived post hoc 
for each vessel and stenosis (FFRCT). Before PCI, the invasive hyperemic 
pressure-wire pullback was performed to derive the apparent FFR 
contribution of each stenosis (FFRpullback). The true FFR attributable to 
individual lesions (FFRtrue) was then measured following PCI of one of 
the lesions. The predictive accuracy of FFRpullback, FFRCT, and the novel 
technique (FFRCT-P) was then assessed against FFRtrue. From the 24 patients 
undergoing the protocol, 19 vessels had post hoc FFRCT and FFRCT-P 
calculation. When assessing the distal effect of all lesions, FFRCT correlated 
moderately well with invasive FFR (R=0.71; P<0.001). For lesion-specific 
assessment, there was significant underestimation of FFRtrue using FFRpullback 
(mean discrepancy, 0.06±0.05; P<0.001, representing a 42% error) and 
conventional trans-lesional FFRCT (0.05±0.06; P<0.001, 37% error). Using 
FFRCT-P, stenosis underestimation was significantly reduced to a 7% error 
(0.01±0.05; P<0.001).
CONCLUSIONS: FFR pullback and conventional FFRCT significantly 
underestimate true stenosis contribution in serial coronary artery disease. 
A novel noninvasive FFRCT-based PCI planner tool more accurately predicts 
the true FFR contribution of each stenosis in serial coronary artery disease.
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Coronary computed tomographic angiography (CTA) is now established as a noninvasive test for the detection of significant coronary artery 
disease (CAD).1,2 Owing to a relatively low positive 
predictive value and inability to determine functional 
significance,2 CTA has generally been used in patients 
at a low to intermediate risk with a view to ruling out 
significant CAD.3 When coronary atheroma is detected, 
there is growing evidence that the benefit of revas-
cularization is only derived from targeting myocar-
dial ischemia.4 Ischemia-guided revascularization has 
evolved to identifying vessels with functionally signifi-
cant disease at the time of angiography using indices 
such as fractional flow reserve (FFR).5–7 In recent years 
it has become possible to estimate FFR from standard 
coronary CTA data sets with FFR by computed tomog-
raphy (FFRCT). Based on computational fluid dynamics 
(CFD), FFRCT has been shown to increase the positive 
predictive value of coronary CTA and provide clinicians 
with a noninvasive test to assess coronary anatomy and 
physiology.8–10
The studies validating both invasive FFR and FFRCT 
have largely been in vessels with single epicardial 
stenoses.9,11 In reality, CAD is often diffuse in na-
ture with serial stenoses across the length of a ves-
sel. Assessment of the contribution of each stenosis is 
challenging because physiological interplay affects the 
FFR attributable to each stenosis.12,13 Coronary CTA 
enables detailed visualization of lesion geometry and 
a potential to evaluate the true pressure drop across 
a stenosis by modeling the hemodynamic interplay 
between serial stenoses.13 FFRCT, therefore, offers the 
potential to predict the functional significance of indi-
vidual stenoses within a serially/diffusely diseased ves-
sel, and therefore, to predict the residual functional 
disease burden following PCI.
In this study, we describe a novel noninvasive FFRCT-
derived PCI planning tool (FFRCT-P), which models phys-
iological interplay between stenoses. This tool is based 
on a reduced order model informed by 3-dimensional 
simulations of blood flow to estimate post-PCI pressure 
loss. In this study we aimed to: (1) characterize the ac-
curacy of estimating individual stenosis significance in 
serially diseased vessels using invasive FFR pullback and 
conventional FFRCT outputs (usually presented as a color 
contour map of FFR change down a vessel) and (2) val-
idate the novel noninvasive FFRCT-P in a clinical cohort of 
patients with serial disease, with the aim of comparing 
the accuracy to estimations made from conventional 
FFR pullback and FFRCT.
METHODS
The data that support the findings of this study are available 
from the corresponding author on reasonable request.
Study Population
All patients recruited to the study gave informed consent. 
Patients had presented with symptoms of stable angina and 
had ≥2 stenoses on an invasive coronary angiogram (>30% 
diameter stenosis by quantified coronary angiography, re-
gardless of whether the stenosis represented a diffuse seg-
ment of disease or whether the stenosis was focal). Patients 
were only eligible if the segments of disease were separated 
by a normal segment of at least 10 mm, if it were felt fea-
sible to treat each lesion independently by PCI. Exclusion cri-
teria were age <18 years, pregnancy, estimated golmerular 
filtration rate <30, previous coronary artery bypass grafting, 
and contraindications to FFR assessment or CTA. Cardiac 
catheterization was performed within 4 weeks of the prior 
CTA scan. The study protocol was approved by the United 
Kingdom Health Research Authority and local research eth-
ics committee (15/LO/2011).
CT Protocol
All patients underwent coronary CT angiography using 
a 2×192-slice dual source CT scanner (Somatom Force, 
Siemens Medical Solutions, Forchheim), Germany. Eight 
hundred microgram of sublingual glyceryl trinitrate was 
administered to all patients along with intravenous meto-
prolol to achieve a heart rate of <65 bpm in sinus rhythm 
and <100 bpm in atrial fibrillation. A total of 85 mL intra-
venous contrast (Omnipaque, GE Healthcare, Princeton, 
NJ) was injected at 5.5 mL/s) by a power injector into the 
WHAT IS KNOWN
• Fractional flow reserve (FFR) is commonly used to 
assess the functional significance of coronary ar-
tery disease with noninvasive estimation using 
FFR by computed tomography (FFRCT) growing in 
popularity.
• Estimating the physiological significance of indi-
vidual stenoses in the commonly encountered sce-
nario of serial/diffuse coronary artery disease but is 
theoretically limited with FFR.
WHAT THE STUDY ADDS
• This study shows that conventional use of FFR and 
FFRCT significantly underestimates true stenosis 
contribution in serial and diffuse coronary artery 
disease.
• This study describes a novel noninvasive FFRCT-
based percutaneous coronary intervention planner 
tool (FFRCT).
• We show that FFRCT more accurately predicts the 
true FFR contribution of each stenosis in serial cor-
onary artery disease, compared with conventional 
FFR pullback and FFRCT outputs.
• The findings of this study would support further 
large-scale studies examining the validity and ap-
plicability of this novel noninvasive percutaneous 
coronary intervention planning tool.
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antecubital vein. Descending aorta contrast triggered, pro-
spective ECG gated scanning with adaptive padding was 
then performed in a single breath-hold technique after a 
10 to 12-second delay. The scanning parameters included a 
heart rate dependent pitch of 0.2 to 0.45 and a gantry ro-
tation time of 250 ms. The tube voltage was selected semi-
automatically, and automated exposure control was used 
for the tube current. Image slices were reconstructed using 
a medium sharp kernel (Bv40), using model-based iterative 
reconstruction strength level 3 (ADMIRE; Siemens Medical 
Solutions, Forchheim, Germany).
FFRCT Protocol
FFRCT analysis was performed by HeartFlow, who were blinded 
to the invasive angiographic and physiological data. FFRCT data 
were derived post hoc from the CTA data set using method-
ology that has been previously described.9,14 In summary, FFRCT 
technology involves extraction of a patient-specific geometric 
model of the coronary arteries from CTA data. Subsequently, 
this is combined with population-derived physiological mod-
els and CFD techniques to solve the governing equations of 
blood flow velocity and pressure under simulated hyperemic 
conditions.14 FFRCT physiological models are based on 3 core 
scientific principles: an allometric scaling law relating coro-
nary flow to myocardial mass and vessel lumen volume, the 
principle of flow regulation of vessel size, and an assumption 
of the predictable reduction of microvascular resistance with 
maximal hyperemia.15
In this study, HeartFlow FFRCT v2.7 was used. This soft-
ware runs on the Amazon Web Services cloud and combines 
deep-learning artificial intelligence methods16 to create phys-
iological models that incorporate vessel lumen volume and 
myocardial mass data.15 Normal HeartFlow FFRCT outputs 
involve a color-coded chart of continuous FFRCT values com-
puted along each vessel. The apparent change in these dis-
crete values across each stenosis within the serially diseased 
vessel was used to define the attributable FFRCT for each ste-
nosis within the serially diseased vessel, using conventional 
FFRCT methods without the planning tool.
Estimation of FFRCT Post-Stenting
To enable the fast recalculation of FFRCT for different planning 
configurations of PCI, an accelerated method for updating 
FFRCT was used (based on a reduced order model derived from 
CFD simulations). Without compromising on the accuracy of 
FFRCT, this approach is able to update FFRCT solutions in real-
time in response to changes in lumen geometry. We ensured 
accuracy was not compromised by comparing the perfor-
mance of FFRCT-P against full conventional FFRCT 3D simulations 
performed on the same models (N=80) and observed that the 
accuracy was statistically equivalent to that of FFRCT (P value 
for equivalence based on 2 one-sided t test=0.01). Initially, 
idealized vessel lumen radii are calculated by first evaluating 
percent diameter stenosis and subsequently calculating the 
radius at which there would be no lumen narrowing (ie, to 
achieve a percent stenosis of zero). Following this, a patient-
specific idealized model is constructed using the idealized 
lumen radii. Finally, a CFD-derived reduced order model is 
used to calculate the updated FFRCT values.
This method involves CFD-derived reduced order model 
based on a flow-dependent resistance model for the epicar-
dial arteries, R=Rin+RslQ, where Rin and Rsl are the intercept and 
slope of the resistance-flow relationship, Q is the flowrate and 
R
P
Q
=
∆
 R= ΔPQ is the resistance posed by the epicardial vessel 
to blood flow. Since these quantities also depend on the ep-
icardial geometry, 2 different flowrates are used to calculate 
Rin and Rsl. In each of the original and idealized geometries, 
2 different boundary conditions, the first being hyperemia as 
described in the previous section and the second being a 40% 
lower resistance, are applied. If the flowrates achieved are Q 
and Q*, and the corresponding resistances calculated from 
CFD simulations are R and R* then:
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If the flow difference achieved, Q*−Q, is too low, then 
the intercept and slope are replaced with a 1D CFD model 
parameterized by lumen area (A), viscosity (μ), density (ρ), as
R
L
Ain
=
8
2
µ pi  and R LdA
A dzsl
=
ρ
3
These resistances are applied on the updated lumen geom-
etry (where lumen radii in the stented region are replaced by 
their idealized values), to solve for flow rates, pressures, and 
FFRCT. For the purposes of this study, FFRCT-P of each stenosis 
was derived following the retrospective application of these 
calculations to CTA images, blinded to invasive FFR values but 
with knowledge of stent size and position. Figure 1 illustrates 
the use of this FFRCT planner tool in action.
Cardiac Catheterization Protocol
Angiography was performed via the right radial artery using 
6Fr catheters. Before catheterization, all patients received 300 
mg of aspirin, 600 mg clopidogrel, and benzodiazepine seda-
tion before local anesthetic was administered. Following ar-
terial puncture, patients received 500 to 1000 μg isosorbide 
dinitrate into the radial artery before cardiac catheters were 
advanced and a further intracoronary bolus before the acqui-
sition of standard diagnostic images.
Invasive Pressure-Wire Data Protocol
Before insertion, the pressure-wire was zeroed outside of 
the body, against a fluid-filled guiding catheter pressure-
transducer positioned at the level of the right atrium. After 
insertion, the pressure sensor was normalized to aortic 
pressure at the coronary ostium, with the guide disengaged 
where necessary. The pressure wire tip was delivered to the 
distal part of the serially-diseased vessel, beyond the distal 
stenosis (far enough to minimize the effect of post-stenotic 
turbulent flow), with wire position documented fluoroscop-
ically. An IV adenosine infusion was administered at a dose 
140 µg kg−1 min−1 via an antecubital vein. FFR was defined 
as the lowest Pd/Pa ratio averaged over 5 cardiac cycles fol-
lowing the onset of adenosine.17 Following documentation 
of FFR, the pressure-wire was pulled back to the guide cath-
eter during continuous adenosine infusion at a constant 
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speed (roughly 1 mm/s). This was done through the whole 
of the vessel, regardless of what the operator felt was a 
significant stenosis.
The apparent change in hyperemic pressure gradient 
across each stenosis following pressure-wire pullback within 
the serially diseased vessel was noted with the attributable 
FFR termed FFRpullback. PCI was then performed, with the 
choice of stenosis treated at the discretion of the operator 
using their conventional practice. Following re-calibration, 
pressure-wire pullback was then repeated (ensuring the 
stented segment no longer poses any pressure gradient). 
The subsequent true change in hyperemic pressure gradient 
across the remaining stenosis in isolation was noted with the 
stenosis-attributable FFR termed FFRtrue (ie, FFR in the vessel 
following PCI of the accompanying serial stenosis). The dif-
ference between FFRtrue and FFRpullback was indicative of the 
degree of stenosis underestimation in serial CAD. The rela-
tionship between the extent of stenosis underestimation and 
total vessel FFR (the cumulative FFR in the vessel before PCI 
when both stenoses were present) was also assessed for each 
invasive and noninvasive index.
Statistical Analysis
SPSS Version 23 (IBM Corp, Armonk, New York) and Prism 
Graphpad 5.0 (GraphPad Software Inc, CA) were used for all 
analyses. Normality was assessed using a visual assessment 
of histograms and Q-Q plots. Continuous data are expressed 
as mean±SD and compared using paired t tests. A 2-tailed 
test of significance was performed for all analyses with 
P<0.05 being considered statistically significant. Correlations 
were assessed using Pearson correlation coefficients (R). 
Bland-Altman analysis was used to compare the differ-
ences between estimated and true value across the range of 
measurements.
In addition, methods were compared in estimating the 
true post-PCI change in FFR across a stenosis. This was done 
by calculating the mean relative error (essentially the error as 
a proportion of the true FFR gradient across the lesion). This 
mean error is essentially calculated by evaluating the absolute 
difference between the true FFR gradient and the predicted 
FFR gradient (either using conventional FFRCT or the novel 
FFRCT-P) and dividing this by the true FFR gradient across the 
stenosis in question.
RESULTS
Twenty-seven patients had prospective CT coronary an-
giography that demonstrated serial CAD in 30 vessels. 
Of these, 5 patients (6 vessels) were excluded as satis-
factory catheter laboratory data could not be obtained 
(reasons were: stenosis deemed too severe to make 
pressure-wire measurements, vessel tortuosity making 
it difficult to pass pressure-wire, and an adverse reac-
tion to adenosine). Of the remaining 24 vessels, 19 
(79%) had satisfactory computation of FFRCT along the 
vessel (Figure  2 for study flow chart). Three patients 
were excluded because of proximal stented segments 
and 2 owing to CTA motion artifacts that precluded 
post hoc FFRCT computation.
Patients included, in the final analysis, had a median 
age of 64.7 years (89% male). The Table summarizes 
the patient demographics and details of the serially 
diseased vessels. FFR of these vessels was 0.67±0.16. 
Total vessel FFRCT of these vessels was 0.68±0.18. The 
Invasive total vessel FFR showed reasonable agreement 
with total vessel FFRCT, in line with previous studies
8,9 
(Pearsons R=0.71). Scatterplot and a Bland-Altman plot 
comparing invasive total vessel FFR with total vessel 
FFRCT are shown in Figure 3.
With FFR pullback, significant underestimation of ste-
nosis contribution occurred, regardless of whether the 
proximal or distal lesion was considered, with a mean 
difference between FFRpullback and FFRtrue of 0.06±0.05 
(P<0.001). This corresponded to a mean relative error 
of 42%. For conventional FFRCT outputs along the 
course of vessels, similar significant underestimation of 
stenosis contribution occurred, with a mean difference 
between FFRCT and FFRtrue of 0.05±0.06 (P<0.001), giv-
ing a mean relative error of 37%.
Estimating True Stenosis Significance 
With Interactive Planner Tool
Using the newly developed interactive FFRCT PCI pla-
nning tool, we were able to estimate the FFR in the 
vessel FFRCT-P following PCI of one of the 2 serial steno-
ses (example case shown in Figure 1). Optimal PCI was 
Figure 1.  Example case showing color contour map of fractional flow 
reserve (FFR) change in a serially diseased vessel with improvement in 
estimation of true stenosis significance with interactive planner tool.  
Left, Example of conventional FFR by computed tomography (FFRCT) output for 
a serially diseased left anterior descending artery (serial stenoses labeled) before 
simulated percutaneous coronary intervention (PCI). The FFRCT value between 
and distal to stenoses is suggested to be 0.93 and 0.80, respectively. Right, 
Results of true measured FFR at point X after PCI of stenosis 2, comparing favor-
ably with FFRCT-derived PCI planning tool (FFRCT-P), following application of novel 
planner tool. Using conventional FFRCT and FFRpullback the underestimation would 
have been more significant (0.93 and 0.91, respectively).
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performed in 13 patients, with pressure wire pullback 
performed following PCI to ensure no residual lumen 
narrowing and pressure drop across the stented portion 
before assessing FFRtrue (Figure 2 study flow chart).
Use of FFRCT-P resulted in a significant improvement in 
the correlation between the predicted FFRCT and FFRtrue, 
following PCI of one of the 2 serial stenoses (R=0.44 
with conventional FFRCT, improving significantly to 
R=0.75 with FFRCT-P; Figure 4). Whilst there was good di-
rect correlation of per-stenosis FFRCT-P to FFRtrue (Pearson 
correlation coefficient 0.75, P=0.001; Figure 4), in a few 
cases there was significant over/under-estimation, par-
ticularly when the baseline total vessel FFR was <0.7). 
Figure 4 also illustrates the performance using FFRpullback. 
FFRCT-P has a better correlation coefficient and a more 
linear fit to the data compared to FFRCT or FFRpullback.
By applying the interactive planner tool on a geom-
etry matching the stent location in the subsequent PCI, 
the absolute value of underestimation fell to 0.01±0.05, 
which corresponded to a mean proportional error of 
7% (Figure 5). The equation performed equally well in 
the 2 cases where one of the 2 stenoses was diffuse 
(stenosis measured >30 mm in length by quantified 
coronary angiography).
DISCUSSION
In this study, we have shown that (1) using an unad-
justed trans-lesional gradient from conventional FFRCT 
outputs leads to significant underestimation of ste-
nosis contribution in serially diseased vessels, similar 
to invasive FFR pullback methods and (2) applying a 
novel interactive PCI planning tool (FFRCT-P), results in a 
significant improvement in the accuracy of predicting 
the residual true FFR contribution of stenoses follow-
ing treatment of accompanying serial stenoses. To our 
knowledge, this is the first description and validation of 
this novel noninvasive method to predict the hemody-
namic outcome of a PCI procedure.
Serial and diffuse CAD is common, particularly 
within aging and diabetic populations, with estimates 
of 25% to 40% prevalence in all patients present-
ing for angiography.18,19 There are, however, several 
well-established limitations of physiological assess-
ment of serial CAD. A simple explanation for this 
Figure 2. Study flow diagram.  
The Figure shows how fractional flow reserve by computed tomography (FFRCT)-derived percutaneous coronary intervention (PCI) planning tool (FFRCT-P) and 
FFRpullback were calculated and subsequently compared with FFRtrue.
Table. Summary of Patient Demographics and Lesion Characteristics
Age, years 64.7 ±12.0
Male 17 (89%)
Hypertension 12 (63%)
Diabetes mellitus 6 (32%)
Smoker 5 (26%)
Hyperlipidemia 15 (79%)
Previous PCI 6 (32%)
Lesion severity (by QCA) 58.9%
Lesion length, mm 11.3
Lesion separation, mm 18.6
Summary of patient demographics and lesion characteristics for 24 patients 
recruited to the study. Data presented as mean values±SD with percentage 
prevalence where relevant. PCI indicates percutaneous coronary intervention; 
and QCA; quantified coronary angiography.
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is that a stenosis provides resistance to blood flow, 
manifesting as a post-stenotic drop in pressure that is 
magnified in hyperemic conditions to give the true FFR 
when present in isolation. When another stenosis or 
diffusely-diseased segment, maximal hyperemia (and, 
therefore, measurement of the true FFR resulting from 
the stenoses) is not possible because of the additional 
resistance to flow, with the situation further compli-
cated by flow turbulence when stenoses are particu-
larly severe, close together and nonconcentric.13,20 The 
techniques previously described to overcome these 
limitations have been complex; requiring measure-
ment of coronary wedge pressure12 or the presence 
of a disease-free daughter branch when serial disease 
involves the left main coronary artery.21 Although it 
has been suggested that resting indices (eg, iFR pull-
back) might result in smaller absolute errors than FFR 
in this setting,22 this is likely to be a reflection of the 
different operating range of resting indices, which are 
also prone to significant error.
At present, conventional FFRCT outputs are presented 
as color-coded maps of coronary arteries showing how 
FFRCT values change down the vessel. These color-coded 
gradients of FFRCT are designed to mirror the changes 
in measured FFR one would expect with a hyperemic 
pressure-wire pullback within the catheter laboratory. 
In keeping with this, our results show that unadjusted 
trans-lesional gradients from these conventional FFRCT 
outputs show a similarly significant degree of stenosis 
underestimation in serially diseased vessels, as is the 
case with invasive FFR pullback. Given that the phys-
iological interplay largely depends on lesion geometry, 
which in turn can be well characterized by CTA tech-
niques, a FFRCT-based technique would be expected to 
Figure 3. Scatter and Bland-Altman plots 
comparing fractional flow reserve by com-
puted tomography (FFRCT) against invasive 
FFR before percutaneous coronary interven-
tion (PCI).  
Left, Scatterplot comparing FFRCT against inva-
sively measured FFR before PCI. Solid lines rep-
resent the best linear fit to the data, and dotted 
lines represents the line of identity (x=y). Right, 
Bland-Altman plot comparing the differences 
between total vessel FFRCT and total vessel FFR. 
Solid line represents the mean difference, and 
dotted lines correspond to the 95% CIs.
Figure 4. Scatter and Bland-Altman plots demonstrating how planner tool improves estimation of FFRtrue.  
Top, Scatterplots comparing the (left to right) FFRpullback, FFR by computed tomography (FFRCT), and FFRCT-derived percutaneous coronary intervention (PCI) planning 
tool (FFRCT-P) against true FFR. Solid lines represent the best linear fit to the data and dotted lines represents the line of identity (x=y). Bottom, Bland-Altman plot 
comparing the differences between FFRtrue and FFRpullback, FFRCT, and FFRCT-P (left to right). Solid line represents the mean difference, and dotted lines correspond to 
the 95% CIs. FFR indicates fractional flow reserve.
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have greater potential at predicting the true physiolog-
ical contribution of an individual stenosis, with the added 
appeal of being a noninvasive technique. Based on this, 
the FFRCT-P has been developed to allow real-time recalcu-
lation of residual FFR after simulating PCI, with the oper-
ator able to choose simulated stent position and length.
Despite the large and significant reduction in mean 
error using the novel FFRCT method (FFRCT-P), the vari-
ance of the error because of serial disease is still ap-
preciable (SD ± 0.05), particularly when the cumulative 
burden of disease in the vessel is high (ie, total FFR low). 
These findings are consistent with previous meta-anal-
yses of FFRCT diagnostic performance that have shown 
reduced accuracy with more severe stenoses.23 This may 
be as a result of limited CT visualization of stenosis ge-
ometry when stenoses are severe but also variability in 
microvascular function which is difficult to predict from 
a noninvasive functional-anatomic test. In addition, the 
geometry of the untreated lesion can change post-PCI 
because of a higher operating pressure and can lead 
to unaccounted changes in FFRCT.
21 There are several 
additional issues when using FFRCT in planning inter-
vention that may limit the utility of such a noninvasive 
tool: Firstly, there is a need to have an appropriate CT 
scan within a few weeks of the planned PCI. Secondly, 
not all prospectively acquired CT scans are of adequate 
quality for FFRCT computation. Within our study, around 
20% of cases could not have post hoc FFRCT computa-
tion because of issues such as phase misalignment. This 
was a rate similar to the NXT trial where 13% of CT 
scans were unsuitable for analysis owing to inadequate 
image quality issues such as phase misalignment, stent-
related artifacts, and blooming.9
Despite these factors, in patients that are able to have 
an adequate quality prospective CT coronary angi-
ogram before planned PCI, FFRCT-P still represents a 
significant improvement to current methods of physi-
ologically assessing serial CAD. Furthermore, it has the 
potential to complement contemporary methods of 
planning PCI, particularly in patients with serial/diffuse 
CAD, without requiring the invasive positioning of a 
coronary guidewire. Further multi-center data will be 
needed to evaluate this tool and its impact of clinical 
decision-making.
Limitations
1. The study is limited by its relatively small sample 
size and, therefore, the results are primarily hypo-
thesis generating and merit further examination 
in a larger population derived from a multicenter 
setting.
2. In addition, FFRCT has not been validated for patients 
with previous coronary artery bypass, previous 
stenting within the same vessel, or significantly 
abnormal left ventricular function, and therefore, 
by extension we excluded these patients, and we 
cannot extrapolate the results from the FFRCT PCI 
planning tool to those patient groups.
Conclusions
FFRCT provides a comparable estimation of FFR values 
obtained from routine invasive pressure-wire pullback 
along a vessel and is prone to a similar degree of phys-
iological underestimation in serial CAD. In this study, 
we provide validation for a novel noninvasive FFRCT-P 
and show it to significantly reduce the error of con-
temporary methods in estimating true stenosis contri-
bution within serially diseased vessels following PCI of 
an accompanying stenosis.
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